Kieran O’Kane's most recent trade in Biodesix Inc was a trade of 1,490 Restricted Stock Units done . Disclosure was reported to the exchange on May 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2025 | 1,490 | 4,468 | - | - | Restricted Stock Units | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2025 | 1,490 | 139,529 | - | - | Common Stock | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 0.36 per share. | 09 May 2025 | 239 | 139,290 | - | 0.4 | 86 | Common Stock |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 0.35 per share. | 09 May 2025 | 238 | 139,052 | - | 0.4 | 84 | Common Stock |
| Biodesix Inc | O’Kane Kieran | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 235,000 | 235,000 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | O’Kane Kieran | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 117,500 | 117,500 | - | - | Restricted Stock Units | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 87,319 | 87,319 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 48,118 | 145,566 | - | - | Common Stock | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 30,534 | 61,067 | - | - | Restricted Stock Units | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 0.92 per share. | 10 Feb 2025 | 17,527 | 128,039 | - | 0.9 | 16,198 | Common Stock |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 16,095 | 48,286 | - | - | Restricted Stock Units | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 1,489 | 5,958 | - | - | Restricted Stock Units | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2024 | 1,490 | 97,910 | - | - | Common Stock | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2024 | 1,490 | 7,447 | - | - | Restricted Stock Units | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.39 per share. | 08 Nov 2024 | 238 | 97,672 | - | 1.4 | 331 | Common Stock |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.40 per share. | 08 Nov 2024 | 224 | 97,448 | - | 1.4 | 314 | Common Stock |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2024 | 1,489 | 8,937 | - | - | Restricted Stock Units | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2024 | 1,489 | 90,093 | - | - | Common Stock | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.60 per share. | 08 Aug 2024 | 345 | 89,748 | - | 1.6 | 552 | Common Stock |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.58 per share. | 08 Aug 2024 | 120 | 89,628 | - | 1.6 | 189 | Common Stock |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2024 | 13,080 | 88,604 | - | - | Common Stock | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2024 | 327 | 0 | - | - | Series A Non-Voting Convertible Preferred Stock | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2024 | 1,489 | 75,992 | - | - | Common Stock | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2024 | 1,489 | 10,426 | - | - | Restricted Stock Units | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.48 per share. | 08 May 2024 | 468 | 75,524 | - | 1.5 | 692 | Common Stock |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2024 | 327 | 327 | - | - | Series A Non-Voting Convertible Preferred Stock | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 35,307 | 35,307 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | O’Kane Kieran | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 128,761 | 128,761 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 64,381 | 64,381 | - | - | Restricted Stock Units | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 32,024 | 79,736 | - | - | Common Stock | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 30,534 | 91,601 | - | - | Restricted Stock Units | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.92 per share. | 08 Feb 2024 | 6,319 | 73,417 | - | 1.9 | 12,111 | Common Stock |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.66 per share. | 08 Feb 2024 | 5,412 | 68,005 | - | 1.7 | 9,009 | Common Stock |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 1,490 | 11,915 | - | - | Restricted Stock Units | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2023 | 5,462 | 48,391 | - | - | Common Stock | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2023 | 3,972 | 0 | - | - | Restricted Stock Units | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2023 | 1,490 | 14,894 | - | - | Restricted Stock Units | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.39 per share. | 08 Aug 2023 | 850 | 47,541 | - | 1.4 | 1,180 | Common Stock |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.27 per share. | 08 Aug 2023 | 849 | 46,692 | - | 1.3 | 1,076 | Common Stock |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 1.62 per share. | 03 Aug 2023 | 6,172 | 42,929 | - | 1.6 | 9,999 | Common Stock |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2023 | 5,461 | 38,454 | - | - | Common Stock | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2023 | 3,972 | 3,972 | - | - | Restricted Stock Units | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2023 | 1,489 | 16,384 | - | - | Restricted Stock Units | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.57 per share. | 08 May 2023 | 1,223 | 37,231 | - | 1.6 | 1,916 | Common Stock |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.58 per share. | 08 May 2023 | 474 | 36,757 | - | 1.6 | 747 | Common Stock |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 52,531 | 52,531 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 122,135 | 122,135 | - | - | Restricted Stock Units | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2023 | 5,461 | 24,992 | - | - | Common Stock | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2023 | 3,971 | 7,944 | - | - | Restricted Stock Units | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.80 per share. | 08 Feb 2023 | 1,999 | 22,993 | - | 1.8 | 3,596 | Common Stock |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2023 | 1,490 | 17,873 | - | - | Restricted Stock Units | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 1.15 per share. | 21 Nov 2022 | 4,347 | 19,531 | - | 1.1 | 4,999 | Common Stock |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2022 | 5,461 | 16,889 | - | - | Common Stock | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2022 | 3,972 | 11,915 | - | - | Restricted Stock Units | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2022 | 1,489 | 19,363 | - | - | Restricted Stock Units | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.04 per share. | 08 Nov 2022 | 952 | 15,937 | - | 1.0 | 992 | Common Stock |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.02 per share. | 08 Nov 2022 | 753 | 15,184 | - | 1.0 | 766 | Common Stock |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2022 | 5,462 | 13,101 | - | - | Common Stock | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2022 | 3,972 | 15,887 | - | - | Restricted Stock Units | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 2.53 per share. | 08 Aug 2022 | 1,673 | 11,428 | - | 2.5 | 4,230 | Common Stock |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2022 | 1,490 | 20,852 | - | - | Restricted Stock Units | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2022 | 5,461 | 9,222 | - | - | Common Stock | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2022 | 3,972 | 19,859 | - | - | Restricted Stock Units | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.83 per share. | 09 May 2022 | 1,583 | 7,639 | - | 1.8 | 2,897 | Common Stock |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2022 | 1,489 | 22,342 | - | - | Restricted Stock Units | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2022 | 23,831 | 23,831 | - | - | Restricted Stock Units | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2022 | 23,831 | 23,831 | - | - | Restricted Stock Units | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 31,055 | 31,055 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Feb 2021 | 31,055 | 0 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 25,599 | 25,599 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Feb 2021 | 25,599 | 0 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 11,564 | 11,564 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 6,162 | 6,162 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 4,212 | 4,212 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 4,211 | 8,423 | - | - | Stock Options (Right to buy) |